F.H. Investments, Inc. (dba Asteria Health)
FDA inspection history in Birmingham, Alabama, 2025
- 1
- Form 483
Every document, by year
- Form 483
2025: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2025One Form 483, at Birmingham, Alabama.
Cited most
Across all F.H. Investments, Inc. (dba Asteria Health) observations on file
- 21 CFR 211.100Written procedures; deviations2
- 21 CFR 211.22Responsibilities of quality control unit2
- 21 CFR 211.110Sampling and testing of in-process materials and drug products1
- 21 CFR 211.113Control of microbiological contamination1
- 21 CFR 211.137Expiration dating1
The complete F.H. Investments, Inc. (dba Asteria Health) file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Sites
Birmingham, Alabama
One Form 483 · 2025 · 10 observations
Latest: Form 483, Dec 19, 2025 →
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2025-12-19 | 483 Form 483 | Birmingham, Alabama | 10 | $99 |
Investigators on these documents
FEI number 3038253438 · most recent document Dec 19, 2025
About F.H. Investments, Inc. (dba Asteria Health)
How many FDA Form 483s has F.H. Investments, Inc. (dba Asteria Health) received?
FDA Intel has 1 Form 483 on file for F.H. Investments, Inc. (dba Asteria Health); the most recent is dated Dec 19, 2025.
When was F.H. Investments, Inc. (dba Asteria Health) last inspected by FDA?
The most recent FDA inspection document on file for F.H. Investments, Inc. (dba Asteria Health) is a Form 483 dated Dec 19, 2025, for the site in Birmingham, Alabama.
What did FDA cite at F.H. Investments, Inc. (dba Asteria Health)?
The regulations cited most in the observations on file for F.H. Investments, Inc. (dba Asteria Health) are 21 CFR 211.100 (Written procedures; deviations), 2 times; 21 CFR 211.22 (Responsibilities of quality control unit), 2 times; 21 CFR 211.110 (Sampling and testing of in-process materials and drug products), 1 time.